Clinical and Genetic Features of Unstable Angina Pectoris Depending on Various Psychosocial Risk Factors

Rizamat Ziyadullaevich Mirzaev; Nasyrova Zarina Akbarovna; Alam Mohd Shazeb

Authors

Rizamat Ziyadullaevich Mirzaev Assistant of the Department of Internal Medicine and Cardiology Department №2, Samarkand State Medical University, Samarkand, Uzbekistan
Nasyrova Zarina Akbarovna DSc, Associate Professor of Internal Medicine and Cardiology Department №2 Samarkand State Medical University, Samarkand, Uzbekistan
Alam Mohd Shazeb Assistant of the Department of Internal Medicine and Cardiology Department №2, Samarkand State Medical University, Samarkand, Uzbekistan

Vol. 2 No. 4 (2024): International Journal of Alternative and Contemporary Therapy

Articles

April 5, 2024

Downloads

View Article

Abstract
How to Cite
Metrics
References

In our study we investigated the association of several biopsychosocial risk factors on the progression of unstable angina pectoris, in particular blood uric acid level, cytokine imbalance, anxiety-depressive syndrome, polymorphism of proinflammatory genes, and basic lipid spectrum parameters. We analyzed the correlation between the studied MC parameters, anxiety parameters, production of immunoregulatory cytokines, polymorphism of proinflammatory genes IL-1β T/C 511 (rs16944) and IL-10 T/C 819 (rs1800871), as well as cholesterol metabolism parameters.

Mirzaev, R. Z., Akbarovna, N. Z., & Shazeb, A. M. (2024). Clinical and Genetic Features of Unstable Angina Pectoris Depending on Various Psychosocial Risk Factors. International Journal of Alternative and Contemporary Therapy, 2(4), 4–8. Retrieved from https://medicaljournals.eu/index.php/IJACT/article/view/214

Download Citation

Kurochkina S.D., Semenova E.V., Tereshchenko Y.V., Semenkin A.A., Nechaeva G.I. Stenocardia with high level of anxiety/ Journal "Lechachashchy Doctor", Issue 3-2017 P.91-95

Depression in gout - Dr. Minutko's blog Posted on Fri, 09/03/2018 - 16:05.

Kadyrova F. et al. Prevalence of asymptomatic hyperuricemia among patients with ischemic heart disease //Zdobutki klinichnichnoї i eksperimentalnaya meditsina. - 2017. - №. 2. - С. 53-56.

Mirzaev R., Tashkenbaeva E., Abdieva G. Modern Approach to Identification of Predictors of Chronic Kidney Disease // Eurasian Journal of Medical and Natural Sciences. - 2022. - Т. 2. - №. 6. - С. 379-385.

Nasirova A. A. CHARACTERISTICS OF QUALITY OF LIFE OF BRONCHIAL ASTHMA, CHRONIC OBSTRUCTIVE Lung Disease AND THEIR COMBINATION // Journal of Cardiorespiratory Research. - 2022. - Т. 3. - №. 3.

Nasirova AA, Babamuradova ZB, Bazarova SA Features of immunologic parameters in patients with chronic obstructive pulmonary disease and bronchial asthma // Journal of Cardiorespiratory Research. - 2020. - Т. 1. - №. 3.

Nasirova AA, Sadikova SN, Kurbanova Z. P. Modern ideas about the role of surface phenotype of lymphocytes in chronic obstructive pulmonary disease and bronchial asthma and their treatment // Vestnik nauki i obrazovanie. - 2020. - №. 13-2 (91). - С. 49-53

Nasyrova Z. A., Abdulloeva M. D., Usarov Sh. A. U. Stratification of risk factors in ischemic heart disease //Journal of cardiorespiratory research. - 2021. - Т. 1. - №. 3. - С. 14-17.

NASYROVA Z. A., TASHKENBAEVA E. N. Influence of PROVOSALITEL CYTOKINS GENES AND TRAVOY-DEPRESSIVE SYNDROME ON ISHEMIC HEART DISEASE PROGRESSION //AXBOROTNOMASI. - С. 53.

Tashkenbaeva E. N. et al. DESTABILIZATION OF ISCHEMIC HEART DISEASE IN PATIENTS WITH ANXIETY-DEPRESSIVE SYNDROME // Vestnik Ekstrechnaya Meditsina. - 2021. - Т. 14. - №. 1. - С. 11-18.

Tashkenbaeva E. N. et al. Peculiarities of the left ventricular systolic function parameters in the acute period of myocardial infarction in young patients //International scientific review of the problems of natural sciences and medicine. - 2019. - С. 124-135.

Tashkenbaeva E. N., Nasyrova Z. A., Mirzaev R. Z. Stratification of chronic ischemic heart disease depending on diagnostic methods and ways of their treatment //Journal of cardiorespiratory research. - 2020. - Т. 1. - №. 3. - С. 28-32.

Sharapova Y. Sh., Abdieva G. A., Nasyrova Z. A. Optimization of antiarrhythmic therapy with the drug levocarnitine in patients with acute myocardial infarction // Scientific research and discoveries of the XXI century. - 2017. - С. 95-98.J.C. Chauvet-Gélinier, B. Trojak, C. Lemogne, et al.Potential influence of Type A personality on plasma C-reactive protein levels in people with diabetes Diabetes Metab, 42 (2016), pp. 88-95

J.C. Eichstaedt, H.A. Schwartz, M.L. Kern, et al.Psychological language on Twitter predicts county-level heart disease mortality Psychol Sci, 26 (2015), pp. 159-169

Negmatovna T. E., Khidirnazarovich T. D., Khudayberdievich Z. S. Study of relation of polymorphism Gene Glut9 with coronary heart disease associated asymptomatic hyperuricemia in Uzbek population //European science review. – 2016. – №. 9-10.

Nery DTF, Ranali J, Zanetta Barbosa D, Marangon Júnior H, Pereira RMA, Pereira PCOA. Excisional Biopsy of the Pyogenic Granuloma in Very High-Risk Patient. Case Rep Dent. 2018 Oct 14;2018:5180385. doi: 10.1155/2018/5180385

Pagidipati NJ, Coles A, Hemal K, Lee KL, Dolor RJ, Pellikka PA, Mark DB, Patel MR, Litwin SE, Daubert MA, Shah SH, Hoffmann U, Douglas PS; PROMISE Investigators. Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: Insights from the PROMISE trial. Am Heart J. 2018 Nov 9;208:28-36. doi: 10.1016/j.ahj.2018.11.002.

Puamo – Всемирная организация здравоохранения | Обновлено 08 ноября 2018 в 10:45

R.M. Teply, K.A. Packard, N.D. White, D.E. Hilleman, J.J. DiNicolantonioTreatment of depression in patients with concomitant cardiac disease Prog Cardiovasc Dis, 58 (2016), pp. 514-528

Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ; CIRT Investigators. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events. N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1809798.

Sposito AC, Berwanger O, de Carvalho LSF, Saraiva JFK. GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data. Cardiovasc Diabetol. 2018 Dec 13;17(1):157. doi: 10.1186/s12933-018-0800-2.

Sriha Belguith A, Beltaief K, Msolli MA, Bouida W, Abroug H, Ben Fredj M, Zemni I, Grissa MH, Boubaker H; ESCor Investigators group, Hsairi M, Nouira S; ESCorT Investigators group. Management of acute coronary syndrome in emergency departments: a cross sectional multicenter study (Tunisia). BMC Emerg Med. 2018 Dec 3;18(1):50. doi: 10.1186/s12873-018-0201-6

Szarek M, White HD, Schwartz GG, Alings M, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Kimura T, Kiss RG, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Tricoci P, Xavier D, Zeiher AM, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial. J Am Coll Cardiol. 2018 Oct 27. pii: S0735-1097(18)38961-7. doi:10.1016/j.jacc.2018.10.039.

Tashkenbaeva E.N., Rajabova N.T., Nasyrova Z.A., Kadirova F. Sh. Impact of lipid metabolism disorders and psychological risk factors on the development of cardiovascular disease among women of different age categories//Journal of Critical Reviews Vol:7, Issue: 12. 2020. P. 991-993

The impact of depression and cardiophobia on quality of life in patients with essential hypertension / D. Tsartsalis [et al.] // Psychiatriki - 2016 Jul-Sep. Vol. 27(3). P. 192-203.

Uric acid in metabolic syndrome: From an innocent bystander to a central player / M. Kanbay [et al.] // European journal of internal medicine. – 2016. – 29. P. 3-8.

Van Montfort, F.A. Meyer, R. von Känel, H. Saner, J.P. Schmid, S. Stauber Positive affect moderates the effect of negative affect on cardiovascular disease-related hospitalizations and all-cause mortality after cardiac rehabilitation Eur J Prev Cardiol, 22 (2015), pp. 1247-1253

Virk HUH, Lo KB, Krittanawong C, Inayat F, Sarwar U, Ghani AR, Witzke C, Janzer S, George JC, Pressman G, Bozorgnia B, Chatterjee S, Figueredo VM. The Effects of Geography on Outcomes of Routine Early Versus Selective Late Revascularization Strategy in the reatment of Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Transatlantic Randomized Controlled Trials. J Clin Med Res. 2018 Dec;10(12):868-876. doi:10.14740/jocmr3585w.

Wang S., Li Y., Song X. et al. (2015) Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis. Journal of translational medicine, 13(1): 209–220.

International Journal of Alternative and Contemporary Therapy

Clinical and Genetic Features of Unstable Angina Pectoris Depending on Various Psychosocial Risk Factors

Authors

Downloads

Similar Articles

Menu

Our Journal

SocialShare

counter

Information